Acne Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global acne drugs market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the acne drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global acne drugs market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters:
Scope
Markets Covered:
1) By Type: Inflammatory Acne Drugs; Non-Inflammatory Acne Drugs
2) By End User: Hospitals and Clinics; Pharmacies and Drug Stores; Others
3) By Therapeutic Class: Retinoids; Antibiotics; Salicylic Acid; Benzoyl Peroxide; Others
Companies Mentioned: Johnson & Johnson; Galderma S.A.; Almirall SA; Bausch Health Companies Inc.; GlaxoSmithKline
Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the acne drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global acne drugs market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters:
- Executive Summary - The executive summary section of the report gives brief overview and summary of the report.
- Report Structure - This section gives the structure of the report and the information covered in various sections.
- Introduction - This section gives the segmentation of the acne drugs market by geography, by type, by end-user and by therapeutic class covered in this report.
- Market Characteristics - The market characteristics section of the report defines and explains the acne drugs market. This chapter includes different products and services covered in the report and basic definitions.
- Different Treatment of Acne - This chapter gives brief on the different treatments available for acne.
- Pipeline Analysis - This chapter in the report briefs on the pipeline of acne drugs.
- Top Acne Drugs - This chapter briefs on top selling acne drugs and their estimated sales.
- Product Introduction and Research On Cannabis-Based Acne Drugs - This chapter briefs on the use of cannabis based drugs for acne treatment and highlights on researches that are going on for the same.
- Trends and Strategies - This chapter includes some of the major trends shaping the global acne drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Impact of COVID-19 - This chapter describes the impact of COVID-19 on the acne drugs industry.
- Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional and Country Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region and country.
- Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
- Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
- Competitive Landscape - This section covers details on the competitive landscape of the global acne drugs market, estimated market shares and company profiles for the leading players.
- Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Opportunities and Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for acne drugs manufacturing companies in terms of product offerings, geographic expansion, price offerings, and target groups.
- Appendix - This section includes details on the abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Type: Inflammatory Acne Drugs; Non-Inflammatory Acne Drugs
2) By End User: Hospitals and Clinics; Pharmacies and Drug Stores; Others
3) By Therapeutic Class: Retinoids; Antibiotics; Salicylic Acid; Benzoyl Peroxide; Others
Companies Mentioned: Johnson & Johnson; Galderma S.A.; Almirall SA; Bausch Health Companies Inc.; GlaxoSmithKline
Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia
Regions: Asia Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Acne Drugs Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure9. Acne Drugs Market Product Pipeline Analysis10. Acne Drugs Market Leading Product Sales
6. Introduction
7. Acne Drugs Market Characteristics
8. Different Treatments of Acne
11. Product Introduction and Research On Cannabis-Based Acne Drugs
12. Acne Drugs Market Trends and Strategies
13. Impact Of COVID-19 On The Acne Drugs Market
14. Global Acne Drugs Market Size and Growth
15. Global Acne Drugs Market Segmentation
16. Acne Drugs Market, Regional and Country Analysis
17. Asia-Pacific Acne Drugs Market
18. Western Europe Acne Drugs Market
19. Eastern Europe Acne Drugs Market
20. North America Acne Drugs Market
21. South America Acne Drugs Market
22. Middle East Acne Drugs Market
23. Africa Acne Drugs Market
24. Global Acne Drugs Market Competitive Landscape
25. Key Mergers and Acquisitions In The Acne Drugs Market
26. Acne Drugs Market Opportunities and Strategies
27. Acne Drugs Market, Conclusions and Recommendations
28. Appendix
Executive Summary
This report describes and explains the acne drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.The acne drugs market reached a value of nearly $3,852.7 million in 2020, having increased at a compound annual growth rate (CAGR) of 0.5% since 2015. The market is expected to grow from $3,852.7 million in 2020 to $6,133.2 million in 2025 at a rate of 9.7%. The market is then expected to grow at a CAGR of 3.5% from 2025 and reach $7,279.7 million in 2030.
The CBD acne drugs market reached a value of nearly $141.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 26.4% since 2015. The market is expected to grow from $141.3 million in 2020 to $354.1 million in 2025 at a rate of 20.2%. The market is then expected to grow at a CAGR of 14.5% from 2025 and reach $697.2 million in 2030.
Growth in the historic period resulted from increase in acne prevalence, rising population, strong economic growth increase in pharmaceutical expenditure, rise in disposable income and increased healthcare expenditure. Factor that negatively affected growth in the historic period was high costs of drugs.
Going forward, faster economic growth, rise in healthcare expenditure, high potential of emerging economies, increasing teenage population and sedentary lifestyles, will drive the growth. Factors that could hinder the growth of the acne drugs market in the future include side effects of drugs, coronavirus pandemic, low per capita healthcare expenditure and alternative acne treatment.
The acne drugs market is segmented by type into inflammatory acne drugs and non-inflammatory acne drugs. The inflammatory acne drugs was the largest segment of the acne drugs market segmented by type, accounting for 59.7% of the total in 2020. Going forward, it is also expected to be the fastest growing segment in the acne drugs market segmented by type, at a CAGR of 10.2% during 2020-2025.
The acne drugs market is segmented by end user into hospitals and clinics, pharmacies and drug stores and others. The pharmacies and drug store end-user segment was the largest segment of the acne drugs market segmented by end-user, accounting for 62.0% of the total in 2020. Going forward, the hospitals and clinics segment is expected to be the fastest growing segment in the acne drugs market segmented by end-user, at a CAGR of 10.0% during 2020-2025.
The acne drugs market is segmented by therapeutic class into retinoids, salicylic acid, benzoyl peroxide, antibiotics and others. The retinoids segment was the largest segment of the acne drugs market segmented by therapeutic class, accounting for 28.2% of the total in 2020. Going forward, the salicylic acid segment is expected to be the fastest growing segment in the acne drugs market segmented by therapeutic class, at a CAGR of 11.3% during 2020-2025.
Asia Pacific was the largest region in the acne drugs market, accounting for 36.6% of the total in 2020. It was followed by North America, and then the other regions. Going forward, the fastest-growing regions in the acne drugs market will be Asia Pacific and North America, where growth will be at CAGRs of 12.7% and 8.4% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 8.1% and 6.5% respectively.
The COVID-19 pandemic has impacted the acne drugs market by decreasing the demand of acne drugs from consumers and affecting the supply chain.
The acne drugs market is fragmented, with a large number of players dominating the market. The top ten competitors in the market made up to 40% of the total market in 2019. The major companies in the industry include Johnson & Johnson, Galderma SA, Almirall SA, Bausch Health Companies Inc., GlaxoSmithKline Plc. among others.
The top opportunities in the acne drugs market segmented by type will arise in the inflammatory segment, which will gain $1,430.8 million of global annual sales by 2025. The top opportunities in segment by end user will arise in the pharmacies and drug stores segment, which will gain $1,410.7 million of global annual sales by 2025. The top opportunities in segment by therapeutic class will arise in the retinoids segment, which will gain $689.4 million of global annual sales by 2025. The acne drugs market size will gain the most in the USA at $642.4 million.
Market-trend-based strategies for the acne drugs market include investing in narrow spectrum antibiotics, development of combination therapies for acne treatment, investing on cannabis products consisting cannabis oil, investing in partnerships to develop new drugs and using social media to market the acne treatment products. Player-adopted strategies in the acne drugs market include strategic agreements and partnerships and launch of new drugs.
To take advantage of the opportunities, the publisher recommends the acne drugs companies to focus on narrow-spectrum antibiotics, new mechanism of action (MOA) treatments, use combination therapy, carry out strategic partnerships to develop new products, expand in emerging markets, provide competitively priced offerings, target hospitals and pharmacies to spread awareness, leverage social media, target the teenage population and target distributors in emerging markets.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Johnson & Johnson
- Galderma S.A.
- Almirall SA
- Bausch Health Companies Inc.
- GlaxoSmithKline
- Reckitt Banckiser Group
- Mayne Pharma Group Limited
- Allergen Plc.
- Cipher Pharmaceuticals
- Sol Gel Advanced Topical Therapy
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- Amgen Inc.
- Abbott
- AstraZeneca
- Eli Lilly and Company
- DAIICHI SANKYO COMPANY, LIMITED
- Sinopharm Group Co., Ltd
- Mylan N.V.
- F. Hoffmann-La Roche Ltd
- Bayer AG
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- Zydus Cadila
- Otsuka Pharmaceutical Co., Ltd.
- Shanghai Pharmaceuticals Holding Co., Ltd
- Jiangsu Hengrui Medicine
- Guangzhou Baiyunshan Pharmaceutical
- China Meheco Co Ltd
- Huadong Medicine Co., Ltd
- Cadila Healthcare Limited
- Ranbaxy Laboratories
- Stiefel Laboratories
- BIOCAD
- Zentiva
- Gedeon Richter Plc
- Polpharma SA Pharmaceutical Works
- Egis Group
- Valeant Pharmaceutical International, Inc.
- GUTHY|RENKER
- Dermira, Inc.
- CFR Pharmaceuticals
- Sanofi
- Estee Lauder Inc.
- Nimue Skincare
Methodology
LOADING...
